质子疗法的最新进展用于治疗头骨底部冠状瘤
Wanghan Li1,2, Yiyuan Zhang3, Xiaowen Wang2,4
1School of Clinical Medicine, Shandong Second Medical University, Weifang, 261053, Shandong, China.
Recent patents on anti-cancer drug discovery
|January 26, 2026
概括
质子疗法是头骨底部胆瘤的标准放射疗法,提供生存益处和增强的安全性. 本综述涵盖了这种罕见瘤的质子疗法的进展和挑战.
科学领域:
- 在瘤学瘤学.
- 辐射瘤学 辐射瘤学
- 神经外科 神经外科
背景情况:
- 头骨底部胆瘤是一种罕见的,生长缓慢的瘤.
- 由于瘤位于关键结构附近,完全切除瘤是很困难的.
- 手术后的放射治疗对于消除疾病至关重要.
研究的目的:
- 审查用于骨基冠状瘤的质子疗法的最新进展.
- 讨论与这种情况的质子疗法相关的挑战.
- 提供对放射治疗策略的全面了解.
主要方法:
- 对底性瘤的质子疗法的当前文献的综述.
- 对质子疗法相比光子疗法的剂量计优势的评估.
- 对关于生存和安全的长期随访数据的分析.
主要成果:
- 质子疗法提供了剂量测量优势,最大限度地减少对周围组织的损伤.
- 长期随访证实了质子疗法对生存的好处和安全性的提高.
- 由于发病率低和成本高,存在有限的前性研究.
结论:
- 质子疗法是用于骨底部冠状瘤的标准放射疗法.
- 在最佳的质子疗法剂量,分成和目标划分方面缺乏共识.
- 需要进一步的研究来应对现有的挑战,并优化治疗策略.
相关概念视频
Sutures of the Skull
10.3K
The human skull is composed of several bones that come together to protect the brain and support the structures of the face. The junctions where these bones meet are called sutures.
Sutures are immobile joints between adjacent bones of the skull. The narrow gap between the bones is filled with dense, fibrous connective tissue that unites the bones. The long sutures located between the skull bones are not straight but instead follow irregular, tightly twisting paths. These twisting lines tightly...
Sutures are immobile joints between adjacent bones of the skull. The narrow gap between the bones is filled with dense, fibrous connective tissue that unites the bones. The long sutures located between the skull bones are not straight but instead follow irregular, tightly twisting paths. These twisting lines tightly...
10.3K
Overview of the Skull
7.6K
The cranium (skull) is the skeletal structure of the head that supports the face and protects the brain. It is subdivided into the facial bones and the brain case, or cranial vault. The facial bones underlie the facial structures, form the nasal cavity, enclose the eyeballs, and support the teeth of the upper and lower jaws.
The cranial vault surrounds and protects the brain and houses the middle and inner ear structures. This cavity is bounded superiorly by the rounded top of the skull, which...
The cranial vault surrounds and protects the brain and houses the middle and inner ear structures. This cavity is bounded superiorly by the rounded top of the skull, which...
7.6K
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
603
Oxygen therapy has emerged as a significant tool in enhancing the quality of life for patients suffering from pulmonary arterial hypertension (PAH). While this therapy has principally been studied on patients with significant hypoxemia, this therapeutic approach helps prevent potential organ damage and can be administered in the comfort of one's home.
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
603
Gene Therapy
27.4K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
27.4K
Proton (¹H) NMR: Chemical Shift
3.3K
Organic molecules primarily contain carbon and hydrogen atoms. While all the hydrogen isotopes are NMR-active, protium or hydrogen-1 is the most abundant. It has a significant energy separation between its nuclear spin states due to its large gyromagnetic ratio. As per Boltzmann's distribution, an increase in the energy separation implies a greater excess population of nuclei available for excitation, resulting in a strong NMR absorption signal.
Absorption signals of all the protium nuclei...
Absorption signals of all the protium nuclei...
3.3K
Extraction: Advanced Methods
1.1K
Metal ions can be separated from one another by complexation with organic ligands–the chelating agent– to form uncharged chelates. Here, the chelating agent must contain hydrophobic groups and behave as a weak acid, losing a proton to bind with the metal. Since most organic ligands used in this process are insoluble or undergo oxidation in the aqueous phase, the chelating agent is initially added to the organic phase and extracted into the aqueous phase. The metal-ligand complex is...
1.1K


